Miriam Triyatni
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Targeting IL-6 Receptor Signaling with Satralizumab in Thyroid Eye Disease: Design of the Phase 3 SatraGO-1 and SatraGO-2 Trials.
Journal: Ophthalmology and therapy
Published: July 21, 2025
Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B.
Journal: The New England journal of medicine
Published: January 08, 2025
Analysis of infection rates in neuromyelitis optica spectrum disorder: Comparing satralizumab treatment in SAkuraMoon, post-marketing, and US-based health claims data.
Journal: Multiple sclerosis and related disorders
Published: December 22, 2024
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod.
Journal: Clinical and translational science
Published: April 12, 2024
Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients.
Journal: Clinical and molecular hepatology
Published: October 23, 2023
A single ascending dose study of single-stranded oligodeoxyribonucleotide RO7062931 in Chinese healthy volunteers.
Journal: Clinical and translational science
Published: October 13, 2022
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial.
Journal: The Lancet. Infectious diseases
Published: August 18, 2022
Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers.
Journal: Clinical and translational science
Published: May 14, 2021
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial.
Journal: The lancet. Gastroenterology & hepatology
Published: January 07, 2021
Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B.
Journal: Hepatology (Baltimore, Md.)
Published: December 23, 2020
A Five-in-One First-in-Human Study To Assess Safety, Tolerability, and Pharmacokinetics of RO7049389, an Inhibitor of Hepatitis B Virus Capsid Assembly, after Single and Multiple Ascending Doses in Healthy Participants.
Journal: Antimicrobial agents and chemotherapy
Published: June 25, 2020
A Single and Multiple Ascending Dose Study of Toll-Like Receptor 7 Agonist (RO7020531) in Chinese Healthy Volunteers.
Journal: Clinical and translational science
Published: January 03, 2020
Last Updated: 09/26/2026